Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
Crossref DOI link: https://doi.org/10.1007/s12094-016-1498-9
Published Online: 2016-03-17
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Arance, A. M.
Berrocal, A.
Lopez-Martin, J. A.
de la Cruz-Merino, L.
Soriano, V.
MartÃn Algarra, S.
Alonso, L.
Cerezuela, P.
La Orden, B.
Espinosa, E.
Funding for this research was provided by:
F. Hoffman-La Roche
Roche Farma Spain
Text and Data Mining valid from 2016-03-17